Contraceptive use in France in 2012 and 2022: a descriptive analysis of two repeated nationwide cross-sectional studies
The French National Health Insurance Fund (Cnam) and the French National Agency for Medicines and Health Products Safety (ANSM) via the Scientific Interest Group EPI-PHARE.
Authors
- Lorraine Poncet (ORCID: https://orcid.org/0000-0002-0530-9483)
- Rosemary Dray‐Spira (ORCID: https://orcid.org/0000-0001-7646-3667)
- Mahmoud Zureik (ORCID: https://orcid.org/0000-0002-8393-4217)
- Karima Hider‐Mlynarz (ORCID: https://orcid.org/0000-0001-9142-6303)
- Noémie Roland (ORCID: https://orcid.org/0000-0002-8079-4263)
- Alain Weill (ORCID: https://orcid.org/0000-0001-8687-9092)
- Romain FORTUNA
Institutions
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Est Créteil (FR)
- Paris-Est Sup (FR)
- Agence Nationale de Sécurité du Médicament et des Produits de Santé (FR)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101488
- Citations
- 1
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 1.88